Harrow, Inc. (HROW) Analyst/Investor Day Transcript

Core Points - The event marks Harrow's inaugural Investor and Analyst Day, indicating a significant step in the company's engagement with investors and analysts [1] - The company will present for approximately 2.5 to 3 hours, followed by a 30-minute Q&A session, suggesting a structured approach to communication with stakeholders [4] Risks and Uncertainties - Harrow's forward-looking statements are subject to various risks and uncertainties, particularly regarding the commercial availability of FDA-approved products and the timely approval of certain drug candidates [2][3] - The company has outlined that these risks are detailed in its SEC filings, specifically in the Risk Factors section of its most recent annual report on Form 10-K and subsequent quarterly earnings reports on Form 10-Q [3]